Study of Oglemilast for the Treatment of Asthma

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether oglemilast is safe and effective in the treatment of allergen-induced asthma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Forest Laboratories

Criteria

Inclusion Criteria:

• Mild atopic asthma

• Hyperreactivity to methacholine

• Exhibit positive response to standard allergen skin prick test

Exclusion Criteria:

• Pulmonary disease other than asthma

• Asthma exacerbation within 4 weeks

• History of substance abuse

• Active cardiac disease